Hatch Question, Gottlieb Response Speak Volumes About DSHEA Reliance
This article was originally published in The Rose Sheet
Executive Summary
Gottlieb is not the first FDA commissioner nominee to profess support for its regulatory framework established by DSHEA, but the focus of Hatch's question serves stronger notice than similar questions asked of previous candidates that the agency authority to enforce in the space does need adjustment.
You may also be interested in...
Durbin Lights Supplement MPL Flare In US Senate
Senate votes down Illinois Democrat’s proposal to amend stopgap appropriations bill with language calling for establishing mandatory products listing program in FDA. But proposal to give FDA MPL authority likely will return in Congress, says Natural Products Association.
Sen. Durbin Will Introduce US Mandatory Supplement Registration Bill
Sen. Durbin has been a critic of FDA’s regulation of VMS product market regulation, putting him at odds with industry stakeholders. But “Dietary Supplement Listing Act” he and Sen. Braun will introduce later in week has support of CHPA and CRN.
FDA Review Of Dietary Ingredients For Pharmacy Compounding Could Open Door To Change DSHEA
FDA could look for Congress to amend DSHEA as it creates a “deep” administrative record on dietary ingredients placed on a list of substances no longer allowed for use by compounding pharmacies, says integrative medicine attorney Alan Dumoff. Pharmacy organizations are writing a citizen petition to ward off what they fear will be an excuse to step-up regulation of supplement manufacturing and marketing.